Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0W7DD
|
||||
| Former ID |
DIB012503
|
||||
| Drug Name |
BAY-44-3428
|
||||
| Synonyms |
APC-1167
|
||||
| Indication | Asthma [ICD10:J45] | Terminated | [1] | ||
| Company |
Celera South San Francisco
|
||||
| Target and Pathway | |||||
| Target(s) | Tryptase | Target Info | Inhibitor | [2] | |
| Reactome | Activation of Matrix Metalloproteinases | ||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010843) | ||||
| REF 2 | Bayer AG to Develop Arris Asthma Compound; Arris to Receive Milestone Payment. 1996 Business Wire | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.